Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2006
Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancerPhilippe Fagnoni, Samuel Limat, Loïc Chaigneau, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 14, 2006
Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancerSamuel Limat, Claire-Hélène Bracco-Nolin, Christine Legat-Fagnoni, et al.Pharmacy World & Science : PWS|March 29, 2003
Antidepressant response and fluvoxamine plasma concentrations: a pilot studyFlorence Schwarzenbach, Christian Netillard, Patricia Demoly, et al.Pharmacoeconomics|January 31, 2009
Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphomaPhilippe Fagnoni, Noel Milpied, Samuel Limat, et al.Bulletin Du Cancer|August 29, 2006
[Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification]Philippe Fagnoni, Samuel Limat, Estelle Hintzy-Fein, et al.Bulletin Du Cancer|November 1, 2006
[Appropriate cytotoxic drug usages in solid tumors: conformity to official labelling and level of scientific evidence]Ludwig Grangeasse, Bruno Coudert, Xavier Pivot, et al.American Journal of Clinical Oncology|April 1, 2008
A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapiesErika Viel, Martin Frederico Demarchi, Loic Chaigneau, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 24, 2025
Carbon footprint of a chemotherapy production unit within a hospital pharmacy: Time for green pharmacyManon Chabane, Christine Fagnoni-Legat, Camille Hosotte, et al.Pharmacy World & Science : PWS|December 24, 2003
Observational study of potential risk factors of medication administration errorsEdgar Tissot, Christian Cornette, Samuel Limat, et al.Clinical Drug Investigation|September 26, 2016
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal TumorsVirginie Nerich, Camille Fleck, Loïc Chaigneau, et al.Pageof 6